Jeffrey Eisenberg
Algemeen Directeur bij XENETIC BIOSCIENCES, INC.
Vermogen: 1 575 $ op 30-04-2024
Profiel
Mr. Jeffrey F.
Eisenberg is a Chief Executive Officer & Director at Xenetic Biosciences, Inc. He is on the Board of Directors at Xenetic Biosciences, Inc. Mr. Eisenberg was previously employed as an Independent Director by MabVax Therapeutics Holdings, Inc., a President by Novogyne Pharmaceuticals, a President, Chief Executive Officer & Director by Noven Pharmaceuticals, Inc., a General Counsel by IVAX Corp., and a Lawyer by Steel Hector & Davis LLP.
He also served on the board at MabVax Therapeutics, Inc. He received his undergraduate degree from The Wharton School of the University of Pennsylvania and a graduate degree from Columbia Law School.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
31-03-2024 | 417 ( 0.03% ) | 1 575 $ | 30-04-2024 |
Actieve functies van Jeffrey Eisenberg
Bedrijven | Functie | Begin |
---|---|---|
XENETIC BIOSCIENCES, INC. | Algemeen Directeur | 26-10-2017 |
Eerdere bekende functies van Jeffrey Eisenberg
Bedrijven | Functie | Einde |
---|---|---|
MABVAX THERAPEUTICS HOLDINGS, INC. | Directeur/Bestuurslid | 31-07-2018 |
Noven Pharmaceuticals, Inc.
Noven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Noven Pharmaceuticals, Inc. operates as a pharmaceutical company with transdermal expertise. It specializes in the research and development, manufacture, marketing, and sale of prescription pharmaceutical products. The company was founded in 1987 and is headquartered in Miami, FL. | Algemeen Directeur | 01-01-2016 |
Novogyne Pharmaceuticals
Novogyne Pharmaceuticals Pharmaceuticals: MajorHealth Technology Novogyne Pharmaceuticals manufactures pharmaceutical products. | President | 01-08-2014 |
IVAX LLC
IVAX LLC Pharmaceuticals: MajorHealth Technology IVAX LLC discovers, develops, manufactures, and markets generic pharmaceuticals, respiratory drugs, and cancer treatments. It offers drugs for the treatment of multiple sclerosis, brain cancer, asthma, and epilepsy. The company was founded by Phillip Frost and Jane H. Hsiao in 1987 and is headquartered in Weston, FL. | Algemeen Adviseur | - |
MabVax Therapeutics, Inc.
MabVax Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology MabVax Therapeutics, Inc. developed and commercialized immunotherapeutics for the treatment of cancer. The company was founded in 2006 and is headquartered in San Diego, CA. | Directeur/Bestuurslid | - |
Opleiding van Jeffrey Eisenberg
The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Columbia Law School | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
XENETIC BIOSCIENCES, INC. | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
Noven Pharmaceuticals, Inc.
Noven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Noven Pharmaceuticals, Inc. operates as a pharmaceutical company with transdermal expertise. It specializes in the research and development, manufacture, marketing, and sale of prescription pharmaceutical products. The company was founded in 1987 and is headquartered in Miami, FL. | Health Technology |
IVAX LLC
IVAX LLC Pharmaceuticals: MajorHealth Technology IVAX LLC discovers, develops, manufactures, and markets generic pharmaceuticals, respiratory drugs, and cancer treatments. It offers drugs for the treatment of multiple sclerosis, brain cancer, asthma, and epilepsy. The company was founded by Phillip Frost and Jane H. Hsiao in 1987 and is headquartered in Weston, FL. | Health Technology |
Steel Hector & Davis LLP
Steel Hector & Davis LLP Miscellaneous Commercial ServicesCommercial Services Part of Squire Patton Boggs (US) LLP, Steel Hector & Davis LLP provides legal services. The company is based in Miami, FL. Steel Hector & Davis was acquired by Squire Sanders (US) LLP on September 06, 2005. | Commercial Services |
MabVax Therapeutics Holdings, Inc.
MabVax Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology MabVax Therapeutics Holdings, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing innovative vaccine and monoclonal antibody-based therapeutics for the diagnosis and treatment of cancer. The company was founded on July 8, 2014 and is headquartered in San Diego, CA. | Health Technology |
Novogyne Pharmaceuticals
Novogyne Pharmaceuticals Pharmaceuticals: MajorHealth Technology Novogyne Pharmaceuticals manufactures pharmaceutical products. | Health Technology |
MabVax Therapeutics, Inc.
MabVax Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology MabVax Therapeutics, Inc. developed and commercialized immunotherapeutics for the treatment of cancer. The company was founded in 2006 and is headquartered in San Diego, CA. | Health Technology |